相关实验视频
Updated: Jan 12, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
30.6K
胆固醇转移蛋白抑制剂的两个面孔
Angela Pirillo1, Alberico L Catapano2,3
1Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello Balsamo.
Current opinion in lipidology
|November 5, 2025
概括
胆固醇转移蛋白 (CETP) 抑制剂,如obicetrapib,通过降低LDL-C和apoB,而不仅仅是提高HDL-C,在动脉样硬化心血管疾病 (ASCVD) 中表现有前途.
科学领域:
- 心血管医学 心血管医学
- 脂质代谢 脂质代谢是什么
- 药理学 药理学是指药理学的学科.
背景情况:
- LDL在ASCVD中的作用很清楚,但HDL的贡献是复杂的.
- 以前的CETP抑制剂未能证明心血管益处,改变了对CETP生物学的看法.
- 对CETP抑制的重新兴趣源自于obicetrapib的发展.
研究的目的:
- 审查关于CETP抑制的最新发现.
- 突出CETP抑制剂的不断变化的观点,从脂质调节到更广泛的临床应用.
- 评估obicetrapib的治疗潜力.
主要方法:
- 临床试验和遗传证据的审查.
- 对obicetrapib的疗效,安全性和非目标效应的分析.
- 对超越ASCVD的CETP抑制影响的初步数据的检查.
主要成果:
- 仅仅增加HDL-C并不能降低心血管风险;降低apoB是有益的.
- 奥比塞特拉皮布显著降低了LDL-C和apoB,显著增加了HDL-C,并且具有良好的安全性.
- 初步数据表明CETP抑制可能会影响糖尿病风险和认知功能.
结论:
- 心血管益处的治疗重点已经从HDL-C升高转向降低apoB.
- 奥比塞特拉皮布在ASCVD管理方面显示出治疗前景.
- 目前正在进行的试验将确定obicetrapib在ASCVD治疗中的最终作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Lipid Absorption
2.4K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Hepatic Drug Clearance: Effect of Protein Binding
511
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
511
Hepatic Drug Excretion: Influencing Factors
516
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
516
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K

